|
DNA2 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 3.613600E-01 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
7.332200E-01 |
| Normal-vs-Stage2 |
1.550060E-02 |
| Normal-vs-Stage3 |
1.775820E-01 |
| Normal-vs-Stage4 |
4.056800E-01 |
| Stage1-vs-Stage2 |
1.770180E-04 |
| Stage1-vs-Stage3 |
5.738100E-02 |
| Stage1-vs-Stage4 |
4.033600E-01 |
| Stage2-vs-Stage3 |
8.140100E-02 |
| Stage2-vs-Stage4 |
5.710500E-02 |
| Stage3-vs-Stage4 |
5.872600E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
4.436200E-01 |
| Normal-vs-AfricanAmerican |
6.083200E-01 |
| Normal-vs-Asian |
4.743000E-01 |
| Caucasian-vs-AfricanAmerican |
9.515800E-01 |
| Caucasian-vs-Asian |
9.483200E-01 |
| AfricanAmerican-vs-Asian |
9.182800E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
5.360400E-01 |
| Normal-vs-Female |
3.199400E-01 |
| Male-vs-Female |
5.187200E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
9.754200E-01 |
| Normal-vs-Age(41-60Yrs) |
4.486000E-02 |
| Normal-vs-Age(61-80Yrs) |
4.953600E-01 |
| Normal-vs-Age(81-100Yrs) |
7.159600E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
3.61770000000261E-05 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
2.237400E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
5.967800E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
4.257800E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
2.143000E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
3.813400E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
3.354000E-01 |
| Classical-VS-Follicular |
6.780200E-01 |
| Classical-VS-Other |
6.380600E-01 |
| Classical-VS-Normal |
5.146800E-01 |
| Tall-VS-Follicular |
5.276600E-01 |
| Tall-VS-Other |
3.317000E-01 |
| Tall-VS-Normal |
2.035000E-01 |
| Follicular-VS-Other |
5.681600E-01 |
| Follicular-VS-Normal |
4.145200E-01 |
| Other-VS-Normal |
9.470200E-01 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
2.494600E-01 |
| Normal-vs-N1 |
8.214200E-01 |
| N0-vs-N1 |
5.114400E-02 |
|
|
